[Federal Register: February 1, 2006 (Volume 71, Number 21)]
[Notices]
[Page 5344]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr01fe06-100]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Vaccines and Related Biological Products Advisory Committee;
Notice of Meeting
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
This notice announces a forthcoming meeting of a public advisory
committee of the Food and Drug Administration (FDA). The meeting will
be open to the public.
Name of Committee: Vaccines and Related Biological Products
Advisory Committee.
General Function of the Committee: To provide advice and
recommendations to the agency on FDA's regulatory issues.
Date and Time: The meeting will be held via teleconference on
February 17, 2006, from 1 p.m. to 5:30 p.m.
Location: National Institutes of Health (NIH) campus, Food and Drug
Administration, Bldg. 29B, conference rooms A and B, 8800 Rockville
Pike, Bethesda, MD. This meeting will be held by teleconference. The
public is welcome to attend. A speakerphone will be provided at the
specified location for public participation in this meeting. Important
information about transportation and directions to the NIH campus,
parking, and security procedures is available on the internet at http://frwebgate.access.gpo.gov/cgi-bin/leaving.cgi?from=leavingFR.html&log=linklog&to=http://www.nih.gov/about/visitor/index.htm.
(FDA has verified the Web site
addresses, but we are not responsible for subsequent changes to the Web
sites after this document publishes in the Federal Register.) Visitors
must show two forms of identification such as a Federal employee badge,
driver's license, passport, green card, etc. If you are planning to
drive to and park on the NIH campus, you must enter at the South Dr.
entrance of the campus which is located on Wisconsin Ave. (the medical
center metro entrance), and allow extra time for vehicle inspection.
Detailed information about security procedures is located at http://frwebgate.access.gpo.gov/cgi-bin/leaving.cgi?from=leavingFR.html&log=linklog&to=http://www.nih.gov/about/visitorsecurity.htm.
Due to the limited available
parking, visitors are encouraged to use public transportation.
Contact Person: Christine Walsh or Denise Royster, Food and Drug
Administration, Center for Biologics Evaluation and Research (HFM-71),
1401 Rockville Pike, Rockville, MD 20852, 301-827-0314, or FDA Advisory
Committee Information Line, 1-800-741-8138 (301-443-0572 in the
Washington, DC area), code 3014512391. Please call the Information Line
for up-to-date information on this meeting.
Agenda: The committee will review and discuss the selection of
strains to be included in the influenza virus vaccine for the 2006-2007
season.
Procedure: Interested persons may present data, information, or
views, orally or in writing, on issues pending before the committee.
Written submissions may be made to the contact person by February 10,
2006. Oral presentations from the public will be scheduled between
approximately 3:30 p.m. and 4:30 p.m. Time allotted for each
presentation may be limited. Those desiring to make formal oral
presentations should notify the contact person before February 10,
2006, and submit a brief statement of the general nature of the
evidence or arguments they wish to present, the names and addresses of
proposed participants, and an indication of the approximate time
requested to make their presentation.
Persons attending FDA's advisory committee meetings are advised
that the agency is not responsible for providing access to electrical
outlets.
FDA welcomes the attendance of the public at its advisory committee
meetings and will make every effort to accommodate persons with
physical disabilities or special needs. If you require special
accommodations due to a disability, please contact Christine Walsh or
Denise Royster at least 7 days in advance of the meeting.
Notice of this meeting is given under the Federal Advisory
Committee Act (5 U.S.C. app. 2).
Dated: January 24, 2006.
Jason Brodsky,
Acting Associate Commissioner for External Relations.
[FR Doc. E6-1224 Filed 1-31-06; 8:45 am]
BILLING CODE 4160-01-S